Words matter. Those two words were woven through a Sunday morning address by Alvin C. Powers, MD, ADA President, Medicine & Science. Today’s researchers and clinicians work in a 140-character, […] Read more

How will diabetes be treated in 2021, 100 years after the discovery of insulin? With selective insulin sensitizers, and by preventing beta-cell dedifferentiation in type 2 diabetes and producing insulin […] Read more

Everything you thought you knew about the causes of diabetes is wrong, according to Michael W. Schwartz, MD. Beta-cell dysfunction and insulin resistance are symptoms, not causes. The real problem […] Read more

During Sunday morning’s Joint ADA/JDRF Symposium—Progress towards an Artificial Pancreas, closed-loop insulin delivery systems received mostly glowing reviews from the session’s expert presenters. Roman Hovorka, PhD, from the University of […] Read more

Tuesday’s ADA Presidents 
Oral Session will highlight this year’s top eight abstracts as selected by the Scientific Sessions Meeting Planning Committee. The two-hour session, which will bring the 77th Scientific […] Read more

Cardiovascular Safety of Insulin Degludec vs. Insulin Glargine in Patients with Type 2 Diabetes at High Risk of Cardiovascular Events (DEVOTE) Trial Results 2:15 p.m.–3:15 p.m. Monday Halls G-H Chair: Steven […] Read more

During a Tuesday morning
 symposium, four researchers will explore the effects of cognitive decline and aging as it relates to diabetes care. They will discuss the psychosomatic effects of out-of-control diabetes and hypoglycemia in conjunction with aging, how to recognize the symptoms of cognitive decline, and what can be done to ensure patients still safely manage their disease. Read more

During Monday afternoon’s 
symposium Successes with Type 1 Diabetes Complications and Survival, four researchers will review the latest data on the development and progression of type 1 diabetes complications. The two-hour symposium will begin at 4:30 p.m. in room 28. Read more

With more than 20,000 children diagnosed with diabetes every year, the American Diabetes Association strives to provide immersive learning experiences through camp programs each year in 25 states, with 54 […] Read more

During A Monday afternoon
 Case Studies session, four experts will review the management of four types of diabetes-related nerve injuries and diseases. The two-hour session, Case-Based Management of Neuropathies, will […] Read more

The Diabetes Prevention Program (DPP) started in 1996, but its benefits continue to improve the lives of those with diabetes and prediabetes, according to Brenda Montgomery, RN, MSHS, CDE, ADA […] Read more

The Diabetes Control and Complications Trial (DCCT) did more than confirm that intensive glucose control can reduce the complications and mortality associated with diabetes. It also established the role of […] Read more

Saturday morning’s ADA Diabetes Care Symposium, Diabetes Care and Research through the Ages, explored changes in diabetes treatment over the years with an eye toward improving care in the future. […] Read more

Growing evidence suggests that diabetes, cancer, and other diseases are linked at the metabolic level. Basic research is beginning to unravel those metabolic pathways and suggest potential targets for translational […] Read more

Looking more closely at the
 developmental origins of pediatric obesity and diabetes will help researchers and clinicians not only develop better ways to treat obesity and diabetes, but perhaps stave […] Read more

Research is uncovering significant information about the role of liver fat in metabolic function, with consequences that extend not only to liver disease but to obesity and diabetes as well. […] Read more

Sunday afternoon’s Physiology of Nervous System Detection of Hypoglycemia symposium will feature four lectures highlighting the latest research into the complex network of neurons involved in glucose homeostasis. The two-hour […] Read more

During Sunday’s symposium
 Patient-Reported Outcomes (PROs)—Using Clinic-Based Screening and Intervention to Inform Diabetes Care, four experts will analyze the benefits and considerations of implementing PROs into routine clinical care. The […] Read more

Researchers are leveraging “omics” and genome-wide association studies (GWAS) to identify new therapeutic pathways to treat diabetes, according to presenters at Friday’s symposium Can “Omic” and Genome-Wide Association Studies (GWAS) […] Read more

This year’s ADA Pathway to Stop Diabetes Symposium features six recent award recipients, who will discuss their research supported by the Pathway to Stop Diabetes® initiative. The two-hour session begins […] Read more

Continuous glucose monitoring (CGM) outcomes provide meaningful metrics for clinical trials and diabetes care, but the benefits can’t be demonstrated without a standard set of definitions, according to a panel […] Read more

Although the latest high-density lipoprotein (HDL) clinical trials have not shown protection against cardiovascular disease, HDL research needs to continue, according to Alan T. Remaley, MD, PhD, one of the […] Read more

Sometimes too much of a good thing is not so good. Such is the case with intensive glycemic control in certain populations. Saturday’s symposium Overtreatment in Diabetes Management will examine the […] Read more

During Saturday’s symposium Population Health, Affordable Care Act (ACA), and New Approaches for Dissemination/Implementation of the Diabetes Prevention Program (DPP), four experts will share real-world lessons learned from DPP implementation across the nation. The two-hour session begins at 4:00 p.m. in room 6DE. Read more

Researchers have tried many approaches to induce beta cells to proliferate and improve function, and most have failed. But several new approaches have emerged, including embryonic stem cells, genetic-based drug […] Read more